From: Homeopathic medical practice for anxiety and depression in primary care: the EPI3 cohort study
GP-Mx vs GP-CM | GP-Ho vs GP-CM | |
---|---|---|
ORc [95 % CI] | ORc [95 % CI] | |
(p value) | (p value) | |
Clinical improvement (HADS score <9b) | ||
All patientsd | 1.49 [0.89–2.50] | 1.70 [1.00–2.87] |
(0.13) | (0.05) | |
HADS ≥12 at inclusion | 1.52 [0.69–3.34] | 1.70 [0.81–3.55] |
(0.30) | (0.16) | |
HADS <12 at inclusion | 1.34 [0.66–2.72] | 1.61 [0.77–3.38] |
(0.42) | (0.21) | |
Psychotropic drug useb | ||
All patientsd | 0.62 [0.41–0.94] | 0.29 [0.19–0.44] |
(0.02) | (<0.001) | |
HADS ≥12 at inclusion | 0.63 [0.38–1.07] | 0.29 [0.18–0.48] |
(0.08) | (<0.001) | |
HADS <12 at inclusion | 0.65 [0.32–1.31] | 0.33 [0.15–0.66] |
(0.23) | (0.003) |